Guideline Summary Chronic limb-threatening ischemia (CLTI) is associated with mortality,
amputation, and impaired quality of life. These Global Vascular Guidelines (GVG) are …

Background and aims Polyvascular disease (PVD) affects approximately 20% of patients
with atherosclerosis and is a strong independent risk factor for ischemic outcomes. However …

Background Antiplatelet agents are central in the management of vascular disease. The use
of dual antiplatelet therapy (DAPT) for the management of thromboembolic complications …

Background Patients with peripheral artery disease are at increased risk for major adverse
cardiac events, major adverse limb events, and all‐cause death. Developing tools capable …

Abstract Aim The “2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS
Guideline for the Management of Lower Extremity Peripheral Artery Disease” provides …

Critical limb ischemia (CLI), defined as ischemic rest pain or nonhealing ulceration due to
arterial insufficiency, represents the most severe and limb-threatening manifestation of …

Background Dual antiplatelet therapy (DAPT) usually refers to the administration of aspirin
plus a platelet P2Y 12 receptor blocker. This combination is commonly prescribed after …

Peripheral arterial disease (PAD) impairs patients' quality of life (QOL), walking and ulcer
healing, increasing patient pain, costs, and risks of amputation or mortality. A literature …

The “2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS guideline for the
management of lower extremity peripheral artery disease: a report of the American College …

Aims Chronic limb-threatening ischaemia (CLTI) entails dismal outcomes and is an absolute
indication to lower extremity revascularization (LER) whenever possible. Antithrombotic …